DekaBank Deutsche Girozentrale
GBIO

DekaBank Deutsche Girozentrale’s Generation Bio GBIO Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,940
Closed -$128K – 1398
2022
Q2 		$128K Hold
1,940
– – ﹤0.01% 1263
2022
Q1 		$139K Buy
1,940
+180
+10% +$10.4K ﹤0.01% 1250
2021
Q4 		$127K Buy
1,760
+50
+3% +$8.73K ﹤0.01% 1324
2021
Q3 		$415K Hold
1,710
– – ﹤0.01% 1090
2021
Q2 		$454K Hold
1,710
– – ﹤0.01% 1085
2021
Q1 		$455K Hold
1,710
– – ﹤0.01% 1044
2020
Q4 		$563K Buy
+1,710
New +$549K ﹤0.01% 998

Other funds holding GBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale's GBIO Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Generation Bio (GBIO) in Q3 2022, closing a stake of 1,940 shares — an estimated $128K sold.

DekaBank Deutsche Girozentrale first reported a position in GBIO in Q4 2020 and held it in 7 quarters. The position peaked at $563K in Q4 2020. 111 funds tracked by Wall St. Rank hold GBIO as of Q3 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Generation Bio position as of Q3 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,940 Generation Bio shares in Q3 2022, an estimated $128K.
  • DekaBank Deutsche Girozentrale first reported a position in Generation Bio in Q4 2020 and held it in 7 quarters.
  • DekaBank Deutsche Girozentrale's Generation Bio position peaked at $563K in Q4 2020.
  • 111 funds tracked by Wall St. Rank held Generation Bio as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.